Matches in Wikidata for { <http://www.wikidata.org/entity/Q88500765> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q88500765 description "article scientifique publié en 2018" @default.
- Q88500765 description "artículu científicu espublizáu n'abril de 2018" @default.
- Q88500765 description "scientific article published on 25 April 2018" @default.
- Q88500765 description "wetenschappelijk artikel" @default.
- Q88500765 description "наукова стаття, опублікована у квітні 2018" @default.
- Q88500765 name "Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases" @default.
- Q88500765 name "Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases" @default.
- Q88500765 type Item @default.
- Q88500765 label "Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases" @default.
- Q88500765 label "Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases" @default.
- Q88500765 prefLabel "Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases" @default.
- Q88500765 prefLabel "Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases" @default.
- Q88500765 P1433 Q88500765-EBE2DAFA-1BB6-42A6-B3B2-4BD32F634CA0 @default.
- Q88500765 P1476 Q88500765-9611C387-54FB-4005-B219-13649DFD41B0 @default.
- Q88500765 P2093 Q88500765-4FFFDF04-19EB-4FFA-B471-85AD67E3FD15 @default.
- Q88500765 P2093 Q88500765-C8EEDB84-E909-439D-9047-240E216350F5 @default.
- Q88500765 P2093 Q88500765-DCF56909-3758-437A-B89B-1691D3C4C5FE @default.
- Q88500765 P304 Q88500765-ADC9C6E8-CA35-42D4-9E88-EC4FB145E52B @default.
- Q88500765 P31 Q88500765-932E57FF-68A2-4498-A8F7-4AA7E3109824 @default.
- Q88500765 P356 Q88500765-21877668-2EE5-4628-B477-77CCB2933ACC @default.
- Q88500765 P433 Q88500765-6AEFF62B-47AA-4F61-80BC-077214632F6A @default.
- Q88500765 P478 Q88500765-F0AF30D1-6F7D-40EA-8DE1-E53B4E51F600 @default.
- Q88500765 P50 Q88500765-3D1400C8-0866-4FE7-AB22-09C6F66180E9 @default.
- Q88500765 P50 Q88500765-634941ED-A8D7-42F7-AEA2-50A830DA6477 @default.
- Q88500765 P50 Q88500765-69C63AB6-901E-4AA2-84C0-75DAA80B72F1 @default.
- Q88500765 P50 Q88500765-71C04317-980E-4205-B286-6E548FEFE294 @default.
- Q88500765 P50 Q88500765-77C8CD83-3C81-4FDC-B56C-E531720EB15F @default.
- Q88500765 P50 Q88500765-82417B38-A01A-4C2B-A3BD-BB7953A641A5 @default.
- Q88500765 P50 Q88500765-D45F7EEA-9E1F-4AA9-B081-ACF9F0A76B59 @default.
- Q88500765 P50 Q88500765-FDB49FD2-B4ED-4F45-9938-08B236D339B1 @default.
- Q88500765 P577 Q88500765-6516B926-8139-47D9-9A19-4D7F2B1E2585 @default.
- Q88500765 P698 Q88500765-22EFB9F0-C1C1-405F-B6CF-43E858AE9140 @default.
- Q88500765 P921 Q88500765-5B70A395-BC52-4B13-BF0E-A062DAFB6237 @default.
- Q88500765 P356 J.CGH.2018.04.040 @default.
- Q88500765 P698 29704680 @default.
- Q88500765 P1433 Q5133759 @default.
- Q88500765 P1476 "Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases" @default.
- Q88500765 P2093 "Ann Gils" @default.
- Q88500765 P2093 "Erwin Dreesen" @default.
- Q88500765 P2093 "Gert Van Assche" @default.
- Q88500765 P304 "1937-1946.e8" @default.
- Q88500765 P31 Q13442814 @default.
- Q88500765 P356 "10.1016/J.CGH.2018.04.040" @default.
- Q88500765 P433 "12" @default.
- Q88500765 P478 "16" @default.
- Q88500765 P50 Q110729292 @default.
- Q88500765 P50 Q114416386 @default.
- Q88500765 P50 Q114416490 @default.
- Q88500765 P50 Q114416531 @default.
- Q88500765 P50 Q30247983 @default.
- Q88500765 P50 Q56849487 @default.
- Q88500765 P50 Q89808750 @default.
- Q88500765 P50 Q96097359 @default.
- Q88500765 P577 "2018-04-25T00:00:00Z" @default.
- Q88500765 P698 "29704680" @default.
- Q88500765 P921 Q917447 @default.